Bimatoprost
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1035 publications
Sustained-Release Intracameral Prostaglandin Analog Implants for Glaucoma: Comparative Review and Meta-Analysis of Bimatoprost and Travoprost Delivery Systems.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: August 03, 2026
Omidenepag isopropyl (Omlonti) for glaucoma.
Journal: The Medical letter on drugs and therapeutics
Published: July 14, 2026
Glaucoma prevalence and prescribing trends in New Zealand: A 10-year study.
Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Published: May 26, 2026
Local Pharmacokinetics and Tolerability of Topically-Applied Bimatoprost to the Scalp of Male Patients With Androgenetic Alopecia.
Journal: Clinical and translational science
Published: May 20, 2026
A Review of Randomized Controlled Trials for Vitiligo Therapies Published Between 2013 and 2023.
Journal: Cureus
Published: May 03, 2026
Preservative-free 0.01% bimatoprost versus other formulations for glaucoma and OHT: Systematic review and meta-analysis of efficacy and safety.
Journal: European journal of ophthalmology
Published: April 01, 2026
Use of Bimatoprost Intracameral Implant for the Treatment of Glaucoma: A Focused Narrative Review.
Journal: Cureus
Published: March 04, 2026
Fixed Triple-Combination Bimatoprost/Brimonidine/Timolol Versus Separate Administration in Glaucoma: Randomized Clinical Trial.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: February 25, 2026
Prostaglandin analogues in cosmetic products formulated for eyelash lengthening.
Journal: Annales pharmaceutiques francaises
Published: February 25, 2026
Fixed Triple-Combination Bimatoprost/Brimonidine/Timolol Versus Separate Administration in Glaucoma: Randomized Clinical Trial.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: February 25, 2026
Twelve-Month Outcomes of Standalone Travoprost Intracameral Implant in Glaucoma or Ocular Hypertension.
Journal: Life (Basel, Switzerland)
Published: February 17, 2026
Differential Effects of EP3, FP, and EP2 Receptor Agonists on Orbital Adipogenesis in a 3D Spheroid Model of Thyroid Eye Disease.
Journal: Current eye research
Published: February 16, 2026
Last Updated: 09/26/2026